Glucosamine
CAS No. 3416-24-8
Glucosamine( —— )
Catalog No. M14160 CAS No. 3416-24-8
Glucosamine is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 45 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlucosamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlucosamine is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies.
-
DescriptionGlucosamine is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies. It is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis. (In Vitro):Glucosamine (D-Glucosamine) exhibits dose-dependent DPPH antioxidant activity.Glucosamine treatment of Short-term (4 h) inhibits HIF-1α at the protein level, decreases phosphorylation of p70S6K and S6, translation-related proteins.Glucosamine significantly decreases renal expression of α-smooth muscle actin, collagen I, and fibronectin in the obstructed kidneys and TGF-β1-treated renal cells.
-
In VitroGlucosamine (D-Glucosamine) exhibits dose-dependent DPPH antioxidant activity. Glucosamine treatment of Short-term (4 h) inhibits HIF-1α at the protein level, decreases phosphorylation of p70S6K and S6, translation-related proteins. Glucosamine significantly decreases renal expression of α-smooth muscle actin, collagen I, and fibronectin in the obstructed kidneys and TGF-β1-treated renal cells.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetCFTR
-
RecptorChitosanase| MMP-9| NF-κB| IFγ| TNF-α
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number3416-24-8
-
Formula Weight179.17
-
Molecular FormulaC6H13NO5
-
Purity>98% (HPLC)
-
SolubilityWater: 551.0 mg/mL
-
SMILESNC(C=O)C(O)C(O)C(O)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fenton JI, et al. Equine Vet J Suppl. 2002 Sep;(34):219-23.
molnova catalog
related products
-
VX-809
VX-809 (Lumacaftor, VRT 826809) is a potent CFTR corrector that increases F508del-CFTR-mediated chloride transport amd improves F508del-CFTR maturation in FRT cells with EC50 of 0.1 and 0.5 uM, respectively.
-
(R)-BPO-27
(R)-BPO-27, the R enantiomer of BPO-27, CFTR chloride conductance with IC50 of 4 nM; BPO-27 S enantiomer is inactive.
-
CFTR corrector 8
CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR).
Cart
sales@molnova.com